MSH2 and colorectal carcinoma: Among MSI CRC patients, the majority appear to exhibit DNA MMR gene MLH1 or MSH2 mutation (Bonadona et al. 2011) or occurrence of hyper-methylation of the MLH1 promoter (Torre et al. 2015).